VolitionRx Limited (NYSE:VNRX) Q2 2021 Results Conference Call August 12, 2021 8:00 AM ET Company Participants Scott Powell - Executive Vice President of Investor Relations Cameron Reynolds - President and Chief Executive Officer Terig Hughes - Chief Financial Officer Thomas Butera - Chief Executive Officer of Volition Veterinary Diagnostics Development Conference Call Participants Bruce Jackson - Benchmark Company Nathan Weinstein - Aegis Capital Steven Ralston - Zacks Investment Research Michael Okunewitc ...